AI驱动药物发现与药学课程思政融合探索-国际教育学-CSCIED科技核心评价数据库-手机版

AI驱动药物发现与药学课程思政融合探索

Exploring the integration of AI-driven drug discovery with ideological and political education in pharmacy curriculum

ES评分 0 浏览量：122 下载量：0

DOI	10.12208/j.ije.20260001
刊名	国际教育学 International Journal of Education
年，卷(期)	2026, 8(1)
作者	胡滨¹, 刘博^1,2, 刘威², 彭芷琪^1,2#, 王贯^1,2,3#,
作者单位	1 大连医科大学附属第二医院辽宁大连 2 四川大学生物治疗全国重点实验室四川成都 3 四川大学华西临床医学院、华西医院四川成都
摘要	随着课程思政在高校不断深化，将专业课程内容与价值引领相融合成为药学教育的重要方向。基于此，研究围绕AI赋能药物研发教学，构建了“专业知识—思政要素—教学设计”三层式课程思政融合框架，以靶点识别、分子设计、ADMET预测等AI药物研发关键环节为载体，系统梳理并嵌入科技伦理、创新精神与社会责任等思政内涵。通过梳理课程知识体系，筛选具有思政价值的药物研发案例，实现专业知识讲授与价值塑造的协同推进。教学实施采用AI辅助的项目驱动学习（AI-PBL）模式，结合案例研讨、虚拟仿真等手段，引导学生在真实问题情境中深化对专业知识的理解，并同步强化科学思维与职业使命感。通过构建涵盖专业知识、工具应用与价值体现的多元化评价机制进行效果评估，为药学课程思政改革提供了系统化、可操作的实践范式。
Abstract	With the continuous advancement of curriculum-based ideological and political education in higher education, integrating disciplinary knowledge with value guidance has become an important direction in pharmaceutical education. Against this background, this study focuses on AI-empowered drug discovery education and proposes a three-layered curriculum integration framework encompassing professional knowledge, ideological–ethical elements, and instructional design. Key stages of AI-driven drug discovery—including target identification, molecular design, and ADMET prediction—are employed as instructional carriers to systematically embed core values such as scientific ethics, innovation awareness, and social responsibility. By restructuring the course knowledge system and selecting drug discovery case studies with clear educational value, the study aims to promote the synergistic integration of knowledge acquisition and value cultivation. In terms of instructional implementation, an AI-assisted project-based learning (AI-PBL) approach is adopted, complemented by case-based discussions and virtual simulation activities. This pedagogical design engages students in authentic problem-solving contexts, enabling deeper understanding of disciplinary knowledge while concurrently fostering scientific reasoning and a sense of professional responsibility. Furthermore, a multi-dimensional evaluation framework encompassing subject knowledge mastery, AI tool application competence, and value-oriented learning outcomes is established to assess the effectiveness of the integrated approach. Collectively, this study offers a systematic and operational pedagogical paradigm that may inform and support curriculum-based ideological and political education reform in pharmaceutical education.
关键词	课程思政；人工智能；药学教育
KeyWord	Ideological-political education; Artificial intelligence; Pharmaceutical education
基金项目
页码	1-7

参考文献
相关文献

[1] OCANA A, PANDIELLA A, PRIVAT C, et al. Integrating artificial intelligence in drug discovery and early drug development: a transformative approach
[J]. Biomark Res, 2025, 13(1): 45.

[2] 姚建庄, 王霞. 基于人工智能技术的计算机辅助药物设计教学改革思路探讨
[J]. 数码设计, 2024, (16): 62-65.

[3] 李珂珂, 李秀莲, 吕青志, et al. 思政教育融入药学专业药剂学课程教学模式探究
[J]. 中国中医药现代远程教育, 2025, 23(10): 37-40.

[4] 赵学梅, 崔红霞, 林宇, et al. 临床药理学课程思政探索
[J]. 药学教育, 2024, 40(4): 24-27.

[5] Araújo-Neto F C, Santos L G D, Tavares T M A, et al. Teaching Strategies for Professional Identity Education in Pharmacy: A Scoping Review
[J]. Am J Pharm Educ, 2024, 88(1): 100597.

[6] 李文芳, 范仲雄, 夏明钰, et al. 思政教育融入《药学》课程的创新型教学研究与实践
[J]. 教育学刊, 2025: 43-49.

[7] 刘丹彤, 钟相根, 贾春华, et al. 金匮要略课程思政建设探索
[J]. 中医教育, 2025, 44(3): 66-70.

[8] 刘广渠, 周文娜, 黄志凌, et al. AI背景下《新药开发设计》教学改革研究
[J]. 教育进展, 2025, 15(10): 393-397.

[9] Alsulami F T. A scoping review on the impact of versatile Digital Health innovations on pharmacy education
[J]. Front Med (Lausanne), 2025, 12: 1577494.

[10] Krishnan S, Blebil A Q, Dujaili J A, et al. Implementation of a hepatitis-themed virtual escape room in pharmacy education: A pilot study
[J]. Educ Inf Technol (Dordr), 2023: 1-13.

[11] 陶丽, 李梢. AI智能教育协同药学导论课程思政路径探索
[J]. 药学教育, 2025, 41(1): 68-72.

[12] 孙王虎, 马鑫, 许立. 如何践行课程思政——以一堂住区设计课为例
[J]. 高等建筑教育, 2025, 34(2): 182-191.

[13] 海洋, 王维, 何伟锋, et al. 课程思政教学方法探究——以"工程化学"课程为例
[J]. 教育教学论坛, 2025, (26): 149-152.

[14] JUMPER J, EVANS R, PRITZEL A, et al. Highly accurate protein structure prediction with AlphaFold
[J]. Nature, 2021, 596(7873): 583-589.

[15] VARADI M, ANYANGO S, DESHPANDE M, et al. AlphaFold Protein Structure Database: massively expanding the structural coverage of protein-sequence space with high-accuracy models
[J]. Nucleic Acids Res, 2022, 50(D1): D439-d444.

[16] TONG X, LIU X, TAN X, et al. Generative Models for De Novo Drug Design
[J]. J Med Chem, 2021, 64(19): 14011-14027.

[17] ZHAVORONKOV A, IVANENKOV Y A, ALIPER A, et al. Deep learning enables rapid identification of potent DDR1 kinase inhibitors
[J]. Nat Biotechnol, 2019, 37(9): 1038-1040.

[18] REN F, ALIPER A, CHEN J, et al. A small-molecule TNIK inhibitor targets fibrosis in preclinical and clinical models
[J]. Nat Biotechnol, 2025, 43(1): 63-75.

[19] GU Y, YU Z, WANG Y, et al. admetSAR3.0: a comprehensive platform for exploration, prediction and optimization of chemical ADMET properties
[J]. Nucleic Acids Res, 2024, 52(W1): W432-w438.

[20] LI P, HUA L, MA Z, et al. Conformalized Graph Learning for Molecular ADMET Property Prediction and Reliable Uncertainty Quantification
[J]. J Chem Inf Model, 2024, 64(23): 8705-8717.

[21] 侯珂露, 黄琳, 封宇飞. 我国药品质量相关的药害事件的回顾性分析
[J]. 中国医院药学杂志, 2020, 40(06): 640-643.

[22] HARRER S, SHAH P, ANTONY B, et al. Artificial Intelligence for Clinical Trial Design
[J]. Trends Pharmacol Sci, 2019, 40(8): 577-591.

[23] ZHANG B, ZHANG L, CHEN Q, et al. Harnessing artificial intelligence to improve clinical trial design
[J]. Commun Med (Lond), 2023, 3(1): 191.

[24] 李宁, 杨敏静, 李羽汐. 医学伦理视角下结直肠癌的数据共享与隐私保护
[J]. 中国医学伦理学, 2024, 37(07): 785-790.

[25] JIN Q, WANG Z, FLOUDAS C S, et al. Matching patients to clinical trials with large language models
[J]. Nat Commun, 2024, 15(1): 9074.

[26] KODUMURU R, SARKAR S, PAREPALLY V, et al. Artificial Intelligence and Internet of Things Integration in Pharmaceutical Manufacturing: A Smart Synergy
[J]. Pharmaceutics, 2025, 17(3).

[27] KATSOULAKIS E, WANG Q, WU H, et al. Digital twins for health: a scoping review
[J]. NPJ Digit Med, 2024, 7(1): 77.

[28] 万春艳. 药学专业VR交互仿真实训中心建设和应用研究
[J]. 实验技术与管理, 2019, 36(01): 238-244.

[29] ALEXANDER K M, EGAN C, FEILD C. Pharmacy students' perceptions and experience using AI tools to complete a drug information assignment: A thematic analysis
[J]. Curr Pharm Teach Learn, 2026, 18(1): 102491.

[30] ERGEZEN SAHIN G, ARAS BAYRAM G, SANCHEZ SIERRA A, et al. Effects of artificial intelligence based physiotherapy educational approach in developing clinical reasoning skills: a randomized controlled trial
[J]. BMC Med Educ, 2025, 25(1): 1378.

[31] 张贵军, 汪乾梁, 彭春祥. 基于语言模型的蛋白质结构域边界预测方法
[J]. 浙江工业大学学报, 2024, 52(05): 521-529.

[32] 解炳腾, 易越, 郝梓凯, et al. 人工智能支持的研究型教学与课程思政协同育人路径探索
[J]. 中国细胞生物学学报, 2025, 47(08): 2012-2019.

[33] 刘佳梅, 刘颖, 李树蕾, et al. 应用AI技术构建的知识图谱开展免疫系统组织学教学实践
[J]. 中国免疫学杂志, 2025, 41(06): 1320-1323.

[34] 魏岩冰. 跨学科视域下的“AI助力胰岛素类药物开发”教学设计
[J]. 生物学教学, 2025, 50(07): 32-34.

[35] 焦磊, 张洋, 李佳敏, et al. 人工智能赋能的药理学教学改革探索
[J]. 药学教育, 2025, 41(03): 76-79.

引用本文

胡滨, 刘博^,, 刘威, 彭芷琪^,#, 王贯^,,#. AI驱动药物发现与药学课程思政融合探索 [J]. 国际教育学. 2026; 8; (1). 1 - 7.

文献评论

相关学者

相关机构